Hainan Huluwa Pharmaceutical Group Co., Ltd. (SHA:605199)
China
· Delayed Price · Currency is CNY 7.06
-0.01 (-0.14%)
Mar 11, 2026, 3:00 PM CST
SHA:605199 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2016 |
| Operating Revenue | 1,057 | 1,407 | 1,782 | 1,515 | 1,354 | 1,162 | Upgrade
|
| Other Revenue | 6.59 | 6.59 | 12.94 | - | - | - | Upgrade
|
| Revenue | 1,064 | 1,414 | 1,795 | 1,515 | 1,354 | 1,162 | Upgrade
|
| Revenue Growth (YoY) | -31.37% | -21.26% | 18.49% | 11.91% | 16.54% | -11.04% | Upgrade
|
| Cost of Revenue | 635.54 | 744.53 | 892.85 | 644.31 | 546.54 | 444.38 | Upgrade
|
| Gross Profit | 428.14 | 669.02 | 902.33 | 870.74 | 807.25 | 717.33 | Upgrade
|
| Selling, General & Admin | 459.39 | 730.07 | 734.51 | 654.11 | 612.94 | 541.56 | Upgrade
|
| Research & Development | 86.01 | 202.08 | 113.66 | 105.66 | 100.43 | 51.66 | Upgrade
|
| Other Operating Expenses | 11.88 | 11.15 | 16.84 | 13.68 | 17.95 | 13.37 | Upgrade
|
| Operating Expenses | 569.62 | 947.38 | 880.59 | 773.21 | 734.55 | 616.78 | Upgrade
|
| Operating Income | -141.49 | -278.36 | 21.74 | 97.52 | 72.7 | 100.55 | Upgrade
|
| Interest Expense | -42.77 | -31.75 | -18.24 | -18 | -13.87 | -9.1 | Upgrade
|
| Interest & Investment Income | - | 10.11 | 1.34 | 2.01 | 3.77 | 0.88 | Upgrade
|
| Currency Exchange Gain (Loss) | - | - | 0 | - | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | 0.19 | 0.48 | -1.34 | -1.08 | 0.02 | 0.06 | Upgrade
|
| EBT Excluding Unusual Items | -184.07 | -299.51 | 3.5 | 80.45 | 62.62 | 92.39 | Upgrade
|
| Gain (Loss) on Sale of Investments | -2.45 | - | -4.43 | -2.06 | -3.66 | -0.49 | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.18 | 0.04 | -0.08 | -0.55 | -0.47 | -0.21 | Upgrade
|
| Asset Writedown | -5.79 | -0.86 | - | - | - | - | Upgrade
|
| Other Unusual Items | 31.12 | 31.17 | 28.04 | 19.38 | 23.18 | 42.7 | Upgrade
|
| Pretax Income | -161.38 | -269.17 | 27.03 | 97.23 | 81.66 | 134.39 | Upgrade
|
| Income Tax Expense | 2.39 | 0.35 | 10.05 | 12.49 | 12.11 | 12.89 | Upgrade
|
| Earnings From Continuing Operations | -163.76 | -269.52 | 16.97 | 84.74 | 69.56 | 121.5 | Upgrade
|
| Minority Interest in Earnings | -4.36 | -4.94 | -6.12 | 0.94 | 2.58 | - | Upgrade
|
| Net Income | -168.12 | -274.46 | 10.85 | 85.68 | 72.14 | 121.5 | Upgrade
|
| Net Income to Common | -168.12 | -274.46 | 10.85 | 85.68 | 72.14 | 121.5 | Upgrade
|
| Net Income Growth | - | - | -87.33% | 18.77% | -40.63% | 0.97% | Upgrade
|
| Shares Outstanding (Basic) | 374 | 398 | 362 | 408 | 401 | 380 | Upgrade
|
| Shares Outstanding (Diluted) | 374 | 398 | 362 | 408 | 401 | 380 | Upgrade
|
| Shares Change (YoY) | 3.98% | 9.97% | -11.35% | 1.81% | 5.55% | 4.13% | Upgrade
|
| EPS (Basic) | -0.45 | -0.69 | 0.03 | 0.21 | 0.18 | 0.32 | Upgrade
|
| EPS (Diluted) | -0.45 | -0.69 | 0.03 | 0.21 | 0.18 | 0.32 | Upgrade
|
| EPS Growth | - | - | -85.71% | 16.67% | -43.75% | -3.03% | Upgrade
|
| Free Cash Flow | 29.26 | -305.35 | -460.95 | -153.61 | -35.14 | -56.12 | Upgrade
|
| Free Cash Flow Per Share | 0.08 | -0.77 | -1.27 | -0.38 | -0.09 | -0.15 | Upgrade
|
| Dividend Per Share | - | - | 0.125 | - | - | 0.150 | Upgrade
|
| Dividend Growth | - | - | - | - | - | -33.33% | Upgrade
|
| Gross Margin | 40.25% | 47.33% | 50.26% | 57.47% | 59.63% | 61.75% | Upgrade
|
| Operating Margin | -13.30% | -19.69% | 1.21% | 6.44% | 5.37% | 8.65% | Upgrade
|
| Profit Margin | -15.81% | -19.42% | 0.60% | 5.66% | 5.33% | 10.46% | Upgrade
|
| Free Cash Flow Margin | 2.75% | -21.60% | -25.68% | -10.14% | -2.60% | -4.83% | Upgrade
|
| EBITDA | -52.38 | -204.99 | 74.11 | 143.77 | 117.46 | 144.06 | Upgrade
|
| EBITDA Margin | -4.92% | -14.50% | 4.13% | 9.49% | 8.68% | 12.40% | Upgrade
|
| D&A For EBITDA | 89.11 | 73.36 | 52.37 | 46.25 | 44.76 | 43.51 | Upgrade
|
| EBIT | -141.49 | -278.36 | 21.74 | 97.52 | 72.7 | 100.55 | Upgrade
|
| EBIT Margin | -13.30% | -19.69% | 1.21% | 6.44% | 5.37% | 8.65% | Upgrade
|
| Effective Tax Rate | - | - | 37.19% | 12.84% | 14.83% | 9.59% | Upgrade
|
| Revenue as Reported | 1,064 | 1,414 | 1,795 | 1,515 | 1,354 | 1,162 | Upgrade
|
| Advertising Expenses | - | 446.81 | 443.11 | 452.11 | 426.22 | 401.89 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.